Jefferies Downgrades Acadia Pharmaceuticals (ACAD) to Hold

Jefferies analyst Chris Howerton downgraded Acadia Pharmaceuticals (NASDAQ: ACAD) from Buy to Hold with a price target of $21.00 (from $40.00).

For an analyst ratings summary and ratings history on Acadia Pharmaceuticals click here. For more ratings news on Acadia Pharmaceuticals click here.

Shares of Acadia Pharmaceuticals closed at $21.18 yesterday.

You May Also Be Interested In

• Nidec Corporation (6594:JP) (NNDNF) PT Lowered to JPY7,900 at CLSA
• Indus Towers Ltd (INDUSTOW:IN) PT Raised to INR310 at CLSA
• Avast Plc. (AVST:LN) (AVASF) PT Raised to GBP p 615 at Goldman Sachs